Omnicell
OMCL
187 hedge funds and large institutions have $1.08B invested in Omnicell in 2014 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 55 increasing their positions, 73 reducing their positions, and 18 closing their positions.
67% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 18
21% more capital invested
Capital invested by funds: $896M → $1.08B (+$188M)
6% more funds holding
Funds holding: 177 → 187 (+10)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
25% less repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 73
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
GW Capital
Bellevue,
Washington
|
+$12.5M |
| 2 |
SAM
Sentinel Asset Management
Montpelier,
Vermont
|
+$9.84M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$6.84M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.47M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.53M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$18.4M |
| 2 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$5.3M |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$5.15M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$4.95M |
| 5 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$3.09M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GVT
201
Genesee Valley Trust
Pittsford,
New York
| – | -$228K | -8,355 | Closed |
|
|
1GA
202
1st Global Advisors
Dallas,
Texas
| – | -$221K | -8,078 | Closed |
|
|
MHS
203
M Holdings Securities
Portland,
Oregon
| – | -$92K | -3,360 | Closed |
|
204
BNP Paribas Financial Markets
Paris,
France
| – | -$60.2K | -2,203 | Closed |
|
|
TRCT
205
Tower Research Capital (TRC)
New York
| – | -$24K | -890 | Closed |
|
OMCL Hedge Fund Activity: Q4 2014 in Review
187 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q4 2014, worth a combined $1.08B — up 21% from $896M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new OMCL positions and 18 closed out — a net gain of 12 holders — while 55 added to existing stakes and 73 trimmed.
The largest buyer was GW Capital, opening a new position worth an estimated $12.5M. The largest seller was JP Morgan Chase, cutting an estimated $18.4M.
- 187 institutional investors held Omnicell (OMCL) as of Q4 2014, up from 177 in Q3 2014.
- Funds reported $1.08B of Omnicell stock for Q4 2014, up 21% quarter-over-quarter.
- 30 funds opened new Omnicell positions in Q4 2014 and 18 closed out, a net change of +12 holders.
- The largest Omnicell buyer in Q4 2014 was GW Capital, an estimated $12.5M added.
- The largest Omnicell seller in Q4 2014 was JP Morgan Chase, an estimated $18.4M sold.
Based on aggregated 13F filings for Q4 2014.